Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
Earlier this week, Cassava also announced plans to extend its open-label extension trials for simufilam by up to 36 months. This will allow patients from previous trials to continue their treatment while awaiting Phase 3 trial results.Cassava Sciences, Inc. (NASDAQ:SAVA) saw its stock price soar Friday, possibly amid rising short interest and an anticipated conference call to discuss recent developments.
Cassava Sciences，Inc.（納斯達克：SAVA）的股價上漲，可能是因爲空頭持倉增加和即將召開的電話會議討論最新進展。
What To Know: The company's short percent of float has risen by 23.21% since its last report, with 16.13 million shares sold short, accounting for 35.89% of the total float. It would take traders an average of 4.75 days to cover their short positions based on the current trading volume.
需要知道的是：公司的空頭比例自上次報告以來上升了23.21％，賣了1613萬股，佔總流通股本的35.89％。根據當前的交易量，交易者需要平均4.75天來持倉購回。
What Else: Cassava Sciences is set to hold a conference call on Thursday August 8 2024, to discuss recent developments and provide a company update. Analysts expect the company to report earnings per share (EPS) loss of $0.40.
其他方面：Cassava Sciences計劃於2024年8月8日星期四召開電話會議，討論最新進展並提供公司更新。分析師們預計公司將報告每股收益爲-0.40美元的虧損。
Earlier this week, Cassava also announced plans to extend its open-label extension trials for simufilam by up to 36 months. This will allow patients from previous trials to continue their treatment while awaiting Phase 3 trial results.
本週早些時候，Cassava還宣佈了將開放標籤延伸試驗時間，將simufilam試驗的時間延長36個月。這將允許之前試驗的患者在等待第3階段試驗結果時繼續接受治療。
SAVA Price Action: Cassava Sciences shares were up by 24.4% at $29.21 according to Benzinga Pro.
SAVA價格行動：據Benzinga Pro報道，Cassava Sciences股票價格上漲24.4％，爲29.21美元。
- Why Ethereum Classic (ETC) Is Falling Today
- 爲什麼以太經典（以太幣）今天下滑？
Image: Courtesy of Cassava Sciences.
圖片：Cassava Sciences提供。
